Resources

Commercial Strategy & Market Access (2)

Study by Veranex and Thermo Fisher Highlights Payer Budget Impact of Novel Test for Kidney Transplant Rejection

By developing a U.S. payer budget impact model and associated manuscript for Thermo Fisher’s Molecular Microscope® MMDx®-Kidney (a microarray with...

Read More

Study by Veranex and Alcon Highlights Time Efficiencies for Femtosecond Laser-Assisted Cataract Surgery

Veranex’s Commercial Strategy team partnered with Alcon in 2020 to design and execute a time-and-motion study comparing Alcon’s femtosecond laser...

Read More

Dasiglucagon Demonstrates Reduced Costs in the Treatment of Severe Hypoglycemia in a Budget Impact Model

Jordan Hinahara and Thomas Goss, members of our Commercial Strategy and Market Access team, contributed to the budget impact model. The objective was...

Read More

Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey....

Read More

Veranex Supports Retrospective Claims Analysis of Physical Therapy Utilization Among Women With Stress or Mixed Urinary Incontinence

Manasi Datar, Li-Chen Pan, and Thomas Goss, members of the Veranex Commercial Strategy and Market Access team, supported the retrospective claims...

Read More

1 min read

Recent Study Co-authored by Veranex Researchers collaborating with a leading U.S. Ophthalmology Practice Highlights Real-World Workflow Efficiencies of Cloud-based Surgical Planning Software in Catara

A research team led by Veranex researchers and a leading U.S, ophthalmology practice recently published results from a real-world time-and-motion...

Read More

A Virtual Tutorial on Regulatory Pathways for Diagnostic Tests in the US and Europe

In this webinar, experts from Goldbug Strategies and Veranex discuss available regulatory pathways for bringing a new generation of innovative...

Read More